|
31 |
Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
Enthalten in Digestive surgery Bd. 36, 2019, Nr. 6: 455-461
|
|
|
|
32 |
Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma
Enthalten in Digestive diseases and sciences 27.9.2018: 1-12
|
|
|
33 |
Combining F-18-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma
Kornberg, Arno. - Ludwig-Maximilians-Universität München, 2017
|
|
|
|
34 |
Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma
Enthalten in Strahlentherapie und Onkologie 25.10.2017: 1-11
|
|
|
|
35 |
Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitis
Michalski, Christoph. - London : BioMed Central, 2016
|
|
|
|
36 |
Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?
Enthalten in Indian journal of medical & paediatric oncology Bd. 37, 2016, Nr. 04: 211-213
|
|
|
|
37 |
English language version of the S3-consensus guidelines on chronic pancreatitis: Definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis
Enthalten in Zeitschrift für Gastroenterologie Bd. 53, 2015, Nr. 12: 1447-1495
|
|
|
|
38 |
Pancreatic cancer-lessons from the past decade
Enthalten in Indian journal of medical & paediatric oncology Bd. 36, 2015, Nr. 02: 73-76
|
|
|
|
39 |
Substance P and neprilysin in chronic pancreatitis
Mascetta, Giuseppe. - Basel : S. Karger AG, 2014
|
|
|
|
40 |
S3-Leitlinie zum exokrinen Pankreaskarzinom
Enthalten in Zeitschrift für Gastroenterologie Bd. 51, 2013, Nr. 12: 1395-1440
|
|
Administration
